{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T13:36:33Z","timestamp":1794317793937,"version":"4.9.0"},"reference-count":133,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.pnpbp.2013.04.009","type":"journal-article","created":{"date-parts":[[2013,4,19]],"date-time":"2013-04-19T09:46:14Z","timestamp":1366364774000},"page":"54-63","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":594,"special_numbering":"C","title":["Monoamine neurocircuitry in depression and strategies for new treatments"],"prefix":"10.1016","volume":"45","author":[{"given":"Michel","family":"Hamon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Blier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2013.04.009_bb0005","first-page":"1","article-title":"Modifying 5-HT1A receptor gene expression as a new target for antidepressant therapy","volume":"4","author":"Albert","year":"2010","journal-title":"Front Neurosci"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0010","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1756-6606-4-21","article-title":"Transcriptional dysregulation of 5-HT1A autoreceptors in mental illness","volume":"4","author":"Albert","year":"2011","journal-title":"Mol Brain"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0015","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1017\/S1461145711001027","article-title":"A double-blind, randomized, placebo-controlled, active reference study of Lu AA21004 in patients with major depressive disorder","volume":"15","author":"Alvarez","year":"2011","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0020","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/mp.2011.26","article-title":"Antidepressants increase human hippocampal neurogenesis by activating the glucocorticoid receptor","volume":"16","author":"Anacker","year":"2011","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0025","first-page":"131","article-title":"Serotonin receptor subtype and p11 mRNA expression in stress-relevant brain regions of suicide and control subjects","volume":"33","author":"Anisman","year":"2008","journal-title":"J Psychiatry Neurosci"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0030","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nature10130","article-title":"NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses","volume":"475","author":"Autry","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0035","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1021\/jm101459g","article-title":"Discovery of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): a novel multimodal compound for the treatment of mood and anxiety disorders","volume":"54","author":"Bang-Andersen","year":"2011","journal-title":"J Med Chem"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0040","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1126\/science.1193692","article-title":"miR-16 targets the serotonin transporter: a new facet for adaptive responses to antidepressants","volume":"329","author":"Baudry","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0045","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1056\/NEJMra073096","article-title":"Major depressive disorder","volume":"358","author":"Belmaker","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0050","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients","volume":"47","author":"Berman","year":"2000","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0055","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/mp.2008.119","article-title":"The mood-improving actions of antidepressants do not depend on neurogenesis but are associated with neuronal remodeling","volume":"14","author":"Bessa","year":"2009","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0060","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/sj.mp.4001401","article-title":"Persistent reduction in brain serotonin1A receptor binding in recovered depressed men measured by positron emission tomography with [11C]WAY-100635","volume":"9","author":"Bhagwagar","year":"2004","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0065","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1523\/JNEUROSCI.03-06-01270.1983","article-title":"Electrophysiological investigations on the effect of zimelidine administration on serotonergic neurotransmission in the rat","volume":"3","author":"Blier","year":"1983","journal-title":"J Neurosci"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0070","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0006-3223(02)01643-8","article-title":"Is there a role for 5-HT1A agonists in the treatment of depression?","volume":"53","author":"Blier","year":"2003","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0075","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.euroneuro.2009.01.015","article-title":"Mirtazapine and paroxetine in major depression: a comparison of monotherapy versus their combination from treatment initiation","volume":"19","author":"Blier","year":"2009","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0080","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1176\/appi.ajp.2009.09020186","article-title":"Combination of antidepressant medications from treatment initiation for major depressive disorder: a double-blind randomized study","volume":"167","author":"Blier","year":"2010","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0085","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jpsychires.2007.05.004","article-title":"Serotonin-1A autoreceptor binding in the dorsal raphe nucleus of depressed suicides","volume":"42","author":"Boldrini","year":"2008","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0090","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1002\/cne.22331","article-title":"Heterogeneous distribution of the serotonin 5-HT1A receptor mRNA in chemically identified neurons of the mouse rostral brainstem: implications for the role of serotonin in the regulation of wakefulness and REM sleep","volume":"518","author":"Bonnavion","year":"2010","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0095","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/sj.bjp.0706935","article-title":"In vivo evidence that 5-HT2C receptors inhibit 5-HT neuronal activity via a GABAergic mechanism","volume":"149","author":"Boothman","year":"2006","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0100","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/mp.2012.52","article-title":"New antidepressant strategy based on acute siRNA silencing of 5-HT1A autoreceptors","volume":"17","author":"Bortolozzi","year":"2012","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0105","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1192\/bjp.163.5.589","article-title":"Prognosis of depression in the elderly. A comparison with younger patients","volume":"163","author":"Brodaty","year":"1993","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0110","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1176\/appi.ajp.161.4.598","article-title":"Lower hippocampal volume in patients suffering from depression: a meta-analysis","volume":"161","author":"Campbell","year":"2004","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0115","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1600-0447.2007.00967.x","article-title":"Pathophysiology of hypercortisolism in depression","volume":"433","author":"Carroll","year":"2007","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0120","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1126\/science.1083968","article-title":"Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene","volume":"301","author":"Caspi","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0125","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1124\/mol.106.022301","article-title":"Fluoxetine and cocaine induce the epigenetic factors MeCP2 and MBD1 in adult rat brain","volume":"70","author":"Cassel","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0130","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.jad.2011.05.057","article-title":"Hippocampal atrophy in first episode depression: a meta-analysis of magnetic resonance imaging studies","volume":"134","author":"Cole","year":"2011","journal-title":"J Affect Disord"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0135","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1016\/j.biopsych.2005.02.027","article-title":"Decreased prefrontal myo-inositol in major depressive disorder","volume":"57","author":"Coupland","year":"2005","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0140","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1017\/S1461145705006413","article-title":"Differential physiological effects of a low dose and high doses of venlafaxine in major depression","volume":"10","author":"Debonnel","year":"2007","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0145","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1523\/JNEUROSCI.0112-04.2004","article-title":"Constitutive activity of the serotonin 2C receptor inhibits in vivo dopamine release in the rat striatum and nucleus accumbens","volume":"24","author":"De Deurwaerd\u00e8re","year":"2004","journal-title":"J Neurosci"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0150","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S0006-3223(99)00014-1","article-title":"Tryptophan-depletion challenge in depressed patients treated with desipramine or fluoxetine: implications for the role of serotonin in the mechanism of antidepressant action","volume":"46","author":"Delgado","year":"1999","journal-title":"Biol Psychiatry"},{"issue":"Suppl. 6","key":"10.1016\/j.pnpbp.2013.04.009_bb0155","first-page":"7","article-title":"Depression: the case for a monoamine deficiency","volume":"61","author":"Delgado","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0160","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1001\/archgenpsychiatry.2010.90","article-title":"A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression","volume":"67","author":"Diazgranados","year":"2010","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb9000","first-page":"223","article-title":"Effects of sustained serotonin reuptake inhibition on the firing of dopamine neurons in the rat ventral tegmental area","volume":"34","author":"Dremencov","year":"2009","journal-title":"J Psychiatry Neurosci"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0165","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.biopsych.2006.05.015","article-title":"Noradrenergic augmentation of escitalopram response by risperidone: electrophysiologic studies in the rat brain","volume":"61","author":"Dremencov","year":"2007","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0170","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00429-008-0189-x","article-title":"Brain and structural and functional abnormalities in mood disorder: implications for neurocircuitry models of depression","volume":"213","author":"Drevets","year":"2008","journal-title":"Brain Struct Funct"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0175","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.nucmedbio.2007.06.008","article-title":"Serotonin-1A receptor imaging in recurrent depression: replication and literature review","volume":"34","author":"Drevets","year":"2007","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0180","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1038\/sj.npp.1301064","article-title":"Effect of antidepressant drugs in mice lacking the norepinephrine transporter","volume":"31","author":"Dziedzicka-Wasylewska","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0185","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1046\/j.1460-9568.2000.00126.x","article-title":"Altered expression and functions of serotonin 5-HT1A and 5-HT1B receptors in knock-out mice lacking the 5-HT transporter","volume":"12","author":"Fabre","year":"2000","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0190","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.brainres.2006.08.029","article-title":"Differential effects of antidepressants on dexamethasone-induced nuclear translocation and expression of glucocorticoid receptor","volume":"1117","author":"Funato","year":"2006","journal-title":"Brain Res"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0195","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1017\/S1461145710000076","article-title":"Characterization of the electrophysiological properties of triple reuptake inhibitors on monoaminergic neurons","volume":"14","author":"Guiard","year":"2011","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0200","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.jad.2011.06.048","article-title":"Abnormal neural activities in first-episode, treatment-na\u00efve, short-illness-duration, and treatment-response patients with major depressive disorder: a resting-state fMRI study","volume":"135","author":"Guo","year":"2011","journal-title":"J Affect Disord"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0205","first-page":"304","article-title":"Enduring cognitive dysfunction in unipolar major depression: a test-retest study using the Stroop paradigm","volume":"51","author":"Hammar","year":"2010","journal-title":"Scand J Psychol"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0210","doi-asserted-by":"crossref","first-page":"S625","DOI":"10.1016\/S0924-977X(06)70008-6","article-title":"Pharmacological profile of antidepressants: a likely basis for their efficacy and side effects?","volume":"16","author":"Hamon","year":"2006","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0215","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1146\/annurev-neuro-061010-113638","article-title":"Deep brain stimulation for psychiatric disorders","volume":"34","author":"Holtzheimer","year":"2011","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0220","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/mp.2011.50","article-title":"Deficient serotonin neurotransmission and depression-like serotonin biomarker alterations in tryptophan hydroxylase 2 (Tph2) loss-of-function mice","volume":"17","author":"Jacobsen","year":"2012","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0225","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1176\/appi.ajp.157.9.1501","article-title":"Does incomplete recovery from first lifetime major depressive episode herald a chronic course of illness?","volume":"157","author":"Judd","year":"2000","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0230","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1001\/archgenpsychiatry.2010.189","article-title":"The serotonin transporter promoter variant(5-HTTLPR), stress, and depression meta-analysis revisited: evidence of genetic moderation","volume":"68","author":"Karg","year":"2011","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0235","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/15622970902717024","article-title":"Beyond the monoaminergic hypothesis: Agomelatine, a new antidepressant with an innovative mechanism of action","volume":"10","author":"Kasper","year":"2009","journal-title":"World J Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0240","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1176\/appi.ajp.163.1.109","article-title":"A Swedish national twin study of lifetime major depression","volume":"163","author":"Kendler","year":"2006","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0245","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1176\/appi.ajp.158.6.899","article-title":"Changes in regional brain glucose metabolism measured with positron emission tomography after paroxetine treatment of major depression","volume":"158","author":"Kennedy","year":"2001","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0250","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ejphar.2010.08.026","article-title":"Sertraline increases extracellular levels not only of serotonin, but also of dopamine in the nucleus accumbens and striatum of rats","volume":"647","author":"Kitaichi","year":"2010","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0255","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S0028-3908(03)00268-5","article-title":"Comparison of effects of dual transporter inhibitors on monoamine transporters and extracellular levels in rats","volume":"45","author":"Koch","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0260","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/cne.20796","article-title":"Differential connections of the perirhinal and parahippocampal cortex with the orbital and medial prefrontal networks in macaque monkeys","volume":"493","author":"Kondo","year":"2005","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fpsyt.2011.00007","article-title":"Functional connectivity of brain structures correlates with treatment outcome in major depressive disorder","volume":"2","author":"Kozel","year":"2011","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1568007043482570","article-title":"5-HT1 receptors","volume":"3","author":"Lanfumey","year":"2004","journal-title":"Curr Drug Targets - CNS Neurol Disord"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0275","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.neubiorev.2008.04.006","article-title":"Corticosteroid-serotonin interactions in the neurobiological mechanisms of stress-related disorders","volume":"32","author":"Lanfumey","year":"2008","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0280","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1126\/science.274.5292.1527","article-title":"Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region","volume":"274","author":"Lesch","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0285","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.biopsych.2005.08.024","article-title":"The genetics of depression: a review","volume":"60","author":"Levinson","year":"2006","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0290","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1126\/science.1190287","article-title":"mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists","volume":"329","author":"Li","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0295","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/S0006-3223(03)00696-6","article-title":"Altered depression-related behaviors and functional changes in the dorsal raphe nucleus of serotonin transporter-deficient mice","volume":"54","author":"Lira","year":"2003","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0300","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1017\/S1461145710001513","article-title":"Neural correlates of treatment outcome in major depression","volume":"14","author":"Lisiecka","year":"2011","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0305","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.biopsych.2009.10.027","article-title":"Reduced density of calbindin immunoreactive GABAergic neurons in the occipital cortex in major depression: relevance to neuroimaging studies","volume":"67","author":"Maciag","year":"2010","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0310","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1098\/rstb.2012.0212","article-title":"Beyond the monoaminergic hypothesis: neuroplasticity and epigenetic changes in a transgenic mouse model of depression","volume":"367","author":"Massart","year":"2012","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0315","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.neuron.2005.02.014","article-title":"Deep brain stimulation for treatment-resistant depression","volume":"45","author":"Mayberg","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0320","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nn.2270","article-title":"Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse","volume":"12","author":"McGowan","year":"2009","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0325","first-page":"41","article-title":"A meta-analysis examining clinical predictors of hippocampal volume in patients with major depressive disorder","volume":"34","author":"McKinnon","year":"2009","journal-title":"J Psychiatry Neurosci"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0330","first-page":"583","article-title":"Psychiatric indications of deep brain stimulation","volume":"194","author":"Millet","year":"2010","journal-title":"Bull Acad Natl Med"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0335","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1001\/archpsyc.1996.01830020031005","article-title":"Clinical and biochemical effects of catecholamine depletion on antidepressant-induced remission of depression","volume":"53","author":"Miller","year":"1996","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0340","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/(SICI)1096-9861(19980808)395:3<310::AID-CNE4>3.0.CO;2-5","article-title":"Hippocampal alpha2a-adrenergic receptors are located predominantly presynaptically but are also found postsynaptically and in selective astrocytes","volume":"395","author":"Milner","year":"1998","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0345","series-title":"The handbook of stress: neuropsychological effects on the brain","first-page":"480","article-title":"How can stress alter emotional balance through its interaction with the serotonergic system?","author":"Mongeau","year":"2011"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb9005","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1471-4159.2010.06932.x","article-title":"5\u2013HT2C receptor activation prevents stress-induced enhancement of brain 5-HT turnover and extracellular levels in the mouse brain: modulation Modulation by chronic paroxetine treatment","volume":"115","author":"Mongeau","year":"2010","journal-title":"J Neurochem"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0350","article-title":"The role of eukaryotic elongation factor 2 kinase in rapid antidepressant action of ketamine","author":"Monteggia","year":"2012","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0355","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1038\/npp.2011.13","article-title":"Pharmacological blockade of 5-HT7 receptors as a putative fast acting antidepressant strategy","volume":"36","author":"Mnie-Filali","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0365","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/00004850-199400910-00008","article-title":"Selective serotonin reuptake inhibitors: meta-analysis of discontinuation rates","volume":"9","author":"Montgomery","year":"1994","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0375","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1124\/jpet.111.189068","article-title":"Pharmacological effects of Lu AA21004: a novel multimodal compound for the treatment of major depressive disorder","volume":"340","author":"M\u00f8rk","year":"2012","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0380","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0014-2999(96)00254-3","article-title":"Interactions of selective serotonin reuptake inhibitors with subtypes of \u03c3 receptors in rat brain","volume":"307","author":"Narita","year":"1996","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0385","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1017\/S0033291709006011","article-title":"Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: a STAR*D report","volume":"40","author":"Nierenberg","year":"2010","journal-title":"Psychol Med"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0390","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0165-0173(87)90011-7","article-title":"Ventral tegmental (A10) system: neurobiology. 1. Anatomy and connectivity","volume":"434","author":"Oades","year":"1987","journal-title":"Brain Res"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0395","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/cne.10609","article-title":"Architectonic subdivision of the human orbital and medial prefrontal cortex","volume":"460","author":"Ong\u00fcr","year":"2003","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0400","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0006-3223(02)01728-6","article-title":"Elevated agonist binding to alpha 2-adrenoceptors in the locus coeruleus in major depression","volume":"53","author":"Ordway","year":"2003","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0405","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1358\/dot.2011.47.7.1622076","article-title":"Vilazodone: a new treatment option for major depressive disorder","volume":"47","author":"Owen","year":"2011","journal-title":"Drugs Today (Barc)"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0410","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0006-3223(01)01145-3","article-title":"Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine","volume":"50","author":"Owens","year":"2001","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0415","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1124\/jpet.102.034280","article-title":"Behavioral and neurochemical effects of 5-{4-[4-(5-cyano-3indolyl)-butyl)-butyl]-1-piperazinyl}-benzofuran-2-carboxamide (EMD 68843): a combined selective inhibitor of serotonin reuptake and 5-hydroxytryptamine 1A receptor partial agonist","volume":"302","author":"Page","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0420","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1007\/s11064-007-9330-0","article-title":"Life-long hippocampal neurogenesis: environmental, pharmacological and neurochemical modulations","volume":"32","author":"Paizanis","year":"2007","journal-title":"Neurochem Res"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0425","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1176\/appi.ajp.159.3.419","article-title":"Higher expression of serotonin 5-HT2A receptors in the postmortem brains of teenage suicide victims","volume":"159","author":"Pandey","year":"2002","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0430","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1038\/sj.npp.1300195","article-title":"The antidepressant clomipramine regulates cortisol intracellular concentrations and glucocorticoid receptor expression in fibroblasts and rat primary neurones","volume":"28","author":"Pariante","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0435","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/sj.bjp.0705357","article-title":"Antidepressant fluoxetine enhances glucocorticoid receptor function in vitro by modulating membrane steroid transporters","volume":"139","author":"Pariante","year":"2003","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0440","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1124\/mol.52.4.571","article-title":"Steroid-independent translocation of the glucocorticoid receptor by the antidepressant desipramine","volume":"52","author":"Pariante","year":"1997","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0445","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1038\/sj.npp.1300992","article-title":"Higher 5-HT1A receptor binding potential during a major depressive episode predicts poor treatment response: preliminary data from a naturalistic study","volume":"31","author":"Parsey","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0450","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.biopsych.2005.06.016","article-title":"Altered serotonin 1A binding in major depression: a [carbonyl-C-11]WAY100635 positron emission tomography study","volume":"59","author":"Parsey","year":"2006","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0455","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1017\/S0033291700033146","article-title":"Residual symptoms after partial remission: an important outcome in depression","volume":"25","author":"Paykel","year":"1995","journal-title":"Psychol Med"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0460","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.euroneuro.2012.04.006","article-title":"Lu AA21004, a novel multimodal antidepressant, produces regionally selective increases of multiple neurotransmitters \u2013 a rat microdialysis and electrophysiological study","volume":"23","author":"Pehrson","year":"2012","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0470","first-page":"533","article-title":"Autoregulation of serotonin neurons: role in antidepressant drug action","volume":"51","author":"Pi\u00f1eyro","year":"1999","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0475","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.biopsych.2005.05.042","article-title":"5-Hydroxytryptamine 1A receptor, major depression, and suicidal behavior","volume":"58","author":"Pitchot","year":"2005","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0480","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0924-977X(03)00108-1","article-title":"Hormonal and temperature responses to flesinoxan in normal volunteers: an antagonist study","volume":"14","author":"Pitchot","year":"2004","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0485","doi-asserted-by":"crossref","first-page":"962","DOI":"10.4088\/JCP.09m05827blu","article-title":"Can we really accelerate and enhance the selective serotonin reuptake inhibitor antidepressant effect? A randomized clinical trial and a meta-analysis of pindolol in nonresistant depression","volume":"72","author":"Portella","year":"2011","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0490","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.tics.2011.12.011","article-title":"Neural circuits underlying the pathophysiology of mood disorders","volume":"16","author":"Price","year":"2012","journal-title":"Trends Cogn Sci"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0495","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/sj.npp.1301234","article-title":"GABAergic neurons immunoreactive for calcium binding proteins are reduced in the prefrontal cortex in major depression","volume":"32","author":"Rajkowska","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0500","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/(SICI)1096-9861(20000207)417:2<181::AID-CNE4>3.0.CO;2-A","article-title":"Somatodendritic localization of 5-HT1A and preterminal axonal localization of 5-HT1B serotonin receptors in adult rat brain","volume":"417","author":"Riad","year":"2000","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0505","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.neuron.2009.12.003","article-title":"5-HT1A autoreceptor levels determine vulnerability to stress and response to antidepressants","volume":"65","author":"Richardson-Jones","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0510","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.4088\/JCP.10ac06470yel","article-title":"New antipsychotic drugs: how do their receptor-binding profiles compare?","volume":"71","author":"Richelson","year":"2010","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0515","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1001\/jama.2009.878","article-title":"Interaction between the serotonin transporter gene (5-HTTLPR), stressful life events, and risk of depression: a meta-analysis","volume":"301","author":"Risch","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0520","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0925-4927(00)00076-7","article-title":"Altered 5-HT2A binding sites and second messenger inositol trisphosphate (IP3) levels in hippocampus but not in frontal cortex from depressed suicide victims","volume":"99","author":"Rosel","year":"2000","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0525","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1176\/appi.ajp.2011.10111645","article-title":"Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study","volume":"168","author":"Rush","year":"2011","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0530","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","article-title":"Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report","volume":"163","author":"Rush","year":"2006","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0535","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/cne.21577","article-title":"Complementary circuits connecting the orbital and medial prefrontal networks with the temporal, insular, and opercular cortex in the macaque monkey","volume":"506","author":"Saleem","year":"2008","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0540","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1023\/A:1006986824213","article-title":"Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding","volume":"19","author":"S\u00e1nchez","year":"1999","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0545","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1212\/WNL.36.8.1130","article-title":"Parkinson's disease with depression: a possible subgroup of idiopathic Parkinsonism","volume":"36","author":"Santamar\u00eda","year":"1986","journal-title":"Neurology"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0550","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1126\/science.1083328","article-title":"Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants","volume":"301","author":"Santarelli","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0555","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0306-4522(98)00256-5","article-title":"Cellular and subcellular localization of 5-hydroxytryptamine1B receptors in the rat central nervous system: immunocytochemical, autoradiographic and lesion studies","volume":"88","author":"Sari","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0560","doi-asserted-by":"crossref","first-page":"4875","DOI":"10.1523\/JNEUROSCI.21-13-04875.2001","article-title":"The alpha(2a)-adrenergic receptor plays a protective role in mouse behavioral models of depression and anxiety","volume":"21","author":"Schramm","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0565","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1111\/j.1476-5381.2011.01770.x","article-title":"Preclinical and clinical characterization of the selective serotonin-1A receptor antagonist DU-125530 for antidepressant treatment","volume":"167","author":"Scorza","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0570","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0893-133X(95)00025-9","article-title":"Serotonin1A receptor activation by flesinoxan in humans. Body temperature and neuroendocrine responses","volume":"13","author":"Seletti","year":"1995","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0575","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.neuroimage.2004.01.015","article-title":"Limbic-frontal circuitry in major depression: a path modeling metanalysis","volume":"22","author":"Seminowicz","year":"2004","journal-title":"Neuroimage"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0580","first-page":"239","article-title":"Use of synthesis inhibitors in defining a role for biogenic amines during imipramine treatment in depressed patients","volume":"1","author":"Shopsin","year":"1975","journal-title":"Psychopharmacol Commun"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0585","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1001\/archpsyc.1976.01770070041003","article-title":"Parachlorophenylalanine reversal of tranylcypromine effects in depressed patients","volume":"33","author":"Shopsin","year":"1976","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0590","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1176\/ajp.154.8.1148","article-title":"Reduced frontal cortex inositol levels in postmortem brain of suicide victims and patients with bipolar disorder","volume":"154","author":"Shimon","year":"1997","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0595","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/0306-4522(81)90146-9","article-title":"Distribution of serotonin-immunoreactivity in the central nervous system of the rat \u2013 cell bodies and terminals","volume":"6","author":"Steinbusch","year":"1981","journal-title":"Neuroscience"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0600","doi-asserted-by":"crossref","first-page":"7394","DOI":"10.1523\/JNEUROSCI.18-18-07394.1998","article-title":"Increase in serotonin-1A autoreceptors in the midbrain of suicide victims with major depression - postmortem evidence for decreased serotonin activity","volume":"18","author":"Stockmeier","year":"1998","journal-title":"J Neurosci"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0605","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1126\/science.1117571","article-title":"Alterations in 5-HT1B receptor function by p11 in depression-like states","volume":"311","author":"Svenningsson","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0610","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1124\/jpet.102.033282","article-title":"Effects of serotonin (5-hydroxytryptamine, 5-HT) reuptake inhibition plus 5\u2013HT2A receptor antagonism on the firing activity of norepinephrine neurons","volume":"302","author":"Szabo","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0615","doi-asserted-by":"crossref","first-page":"246","DOI":"10.4088\/JCP.v69n0211","article-title":"Clinical evidence and potential neurobiological underpinnings of unresolved symptoms of depression","volume":"69","author":"Trivedi","year":"2008","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0620","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0893-133X(00)00220-7","article-title":"Assessment of the serotonin and norepinephrine reuptake blocking properties of duloxetine in healthy subjects","volume":"24","author":"Turcotte","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0625","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1176\/ajp.156.9.1456","article-title":"Prediction of level of serotonin 2A receptor binding by serotonin receptor 2A genetic variation in postmortem brain samples from subjects who did or did not commit suicide","volume":"156","author":"Turecki","year":"1999","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0630","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1176\/appi.ajp.161.11.1957","article-title":"Hippocampal volume and depression: a meta-analysis of MRI studies","volume":"161","author":"Videbech","year":"2004","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0640","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1161\/01.CIR.0000130847.18666.39","article-title":"Clinical assessment of norepinephrine transporter blockade through biochemical and pharmacological profiles","volume":"109","author":"Vincent","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0645","series-title":"Neurotransmitters and neuromodulators","author":"Von Bohlen und Halbach","year":"2006"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0650","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/nn1276","article-title":"Epigenetic programming by maternal behavior","volume":"7","author":"Weaver","year":"2004","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0655","first-page":"47","article-title":"In vitro and in vivo effects of the multimodal antidepressant vortioxetine (Lu AA21004) at human and rat targets","volume":"16","author":"Westrich","year":"2012","journal-title":"Int J Psychiatry Clin Pract"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0660","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0665","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neuron.2004.12.014","article-title":"Loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression","volume":"45","author":"Zhang","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.pnpbp.2013.04.009_bb0680","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.brainres.2010.10.104","article-title":"Altered white matter integrity in first-episode, treatment-na\u00efve young adults with major depressive disorder: a tract-based spatial statistics study","volume":"1369","author":"Zhu","year":"2011","journal-title":"Brain Res"},{"issue":"2 Suppl.","key":"10.1016\/j.pnpbp.2013.04.009_bb0675","doi-asserted-by":"crossref","first-page":"52S","DOI":"10.1016\/S0893-133X(99)00047-0","article-title":"Altered emotional states in knockout mice lacking 5-HT1A or 5-HT1B receptors","volume":"21","author":"Zhuang","year":"1999","journal-title":"Neuropsychopharmacology"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584613000754?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584613000754?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T08:00:15Z","timestamp":1715241615000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584613000754"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":133,"alternative-id":["S0278584613000754"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2013.04.009","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Monoamine neurocircuitry in depression and strategies for new treatments","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2013.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}